SURG financial statements and SEC filings
SURG annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $56.96M | -$34.14M | -$36.07M | 10-K |
| 2024-12-31 | $60.88M | -$43.46M | -$45.73M | 10-K |
| 2023-12-31 | $137.14M | $18.87M | $20.62M | 10-K |
| 2022-12-31 | $121.54M | $633.78K | -$680.76K | 10-K |
| 2021-12-31 | $51.06M | -$5.99M | -$13.53M | 10-K |
| 2020-12-31 | $54.41M | -$10.15M | -$10.72M | 10-K |
SURG annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $8.52M | $23.92M | -$15.40M | 10-Q |
| 2024-12-31 | $23.98M | $8.71M | $15.26M | 10-K |
| 2023-12-31 | $41.93M | $13.52M | $28.40M | 10-K |
| 2022-12-31 | $34.00M | $28.89M | $5.12M | 10-K |
| 2021-12-31 | $19.50M | $15.95M | $3.55M | 10-K |
| 2020-12-31 | $7.33M | $18.05M | -$10.73M | 10-K |
SURG annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$21.29M | -$18.59K | $10.53M | 10-K |
| 2024-12-31 | -$21.31M | -$518.19K | $22.48M | 10-K |
| 2023-12-31 | $10.29M | – | -$2.42M | 10-K |
| 2022-12-31 | $793.27K | -$11.40K | $1.46M | 10-K |
| 2021-12-31 | -$15.29M | -$51.41K | $21.27M | 10-K |
| 2020-12-31 | -$4.33M | -$6.61K | $4.65M | 10-K |